News

Grand Rounds - 10/8/14
10/09/2014

At Grand Rounds this week, Senior Research Scientist,  Dr. Violaine Harris discussed the clinical need for CSF biomarker testing in MS and reviewed current research into the discovery and validation of CSF biomarkers. She highlighted the research from Tisch MS showing that a specific biomarker called Fetuin-A can be an accurate indicator of disease activity and therapeutic response. 

Dr. Violaine Harris and Dr. Saud A. Sadiq recently co-authored a review accepted for publication in the "Journal Molecular Diagnosis and Therapy."
10/06/2014

10/6/14 - Visit the link below or www.tischms.org to learn more. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245485/

Eid Mubarak
10/03/2014

The IMSMP would like to wish all of those observing with their families, a happy Eid Al Adha!

G'mar Chatimah Tova!
10/03/2014

The IMSMP would like to wish our Jewish patients, friends and supporters an easy fast on this Yom Kippur.

More Exciting Discoveries from the Tisch MS Research Lab
09/26/2014

The journal "Neurology® Neuroimmunology and Neuroinflammation," accepted a paper by Dr. Fozia Mir for Publication.  Visit the Tisch MS Research Center of New York at www.tischms.org to learn more.

The International Multiple Sclerosis Management Practice wishes everyone celebrating Rosh Hashanah a healthy and happy new year. L'Shanah Tovah
09/25/2014

Medscape Medical News Reviews Stem Cell Research

09/17/2014

9/16/14 - Medscape Medical News recently reviewed the stem cell research presented at the 2014 Joint Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS/ECTRIMS).  Read the full article below.

Tisch MS Research Center in September Issue of "Neurology Today"
09/13/2014

9/12/14 - Tisch MS Research Center of New York is proud to be featured in the September 2014 issue of “Neurology Today.” The article “Myelinating Oligodendrocytes Derived from Primary Progressive MS Patients: Scientists Developed Faster, More Efficient Methodology,” discusses research focusing on an accelerated protocol to induce stem cells into becoming oligodendrocytes, the myelin-forming cells of the central nervous system....

more

Optimizing Treatment - Understanding Progression (OPT-UP) Study Announced
09/11/2014

9/10/14 - EMD Serono and Accelerated Cure Project Launch Collaborative Research Program to Optimize Treatment and Understand Progression of Multiple Sclerosis.  Tisch MS Research Center of New York is proud to be a participating site in this longitudinal clinical research study.  For more information, contact (212) 265-8070 and ask to speak with a Clinical Research Assistant. Read the full press release here:

...

more

FDA approves Plegridy (peginterferon beta-1a)

08/19/2014

By Dr. James W. Stark

The FDA has approved Plegridy, which is a pegylated (long-acting) formulation of Avonex. Plegridy is administered every other week, subcutaneously (instead of intramuscularly) but is otherwise similar to Avonex in terms of efficacy and side effect profile. This medication should become available to patients soon. If you would like to learn more, please bring it up with your physician at your next office visit. 

 

Pages

IMSMP

Because you deserve only the best in MS healthcare. Experience the difference.

521 West 57th Street

4th Floor

New York, NY 10019

p: 212.265.8070

f: 212.265.8194

Privacy Policy

        

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.